Arkolith/Insider Trading/COGT/Form 4

Pinnow Cole

Chief Commercial OfficerCogent Biosciences, Inc. (COGT) · full profile →Form 4 · filed Dec 19, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 17, 2025Grant(A)214K—$0311K
Dec 17, 2025Tax withholding(F)95K$39.45$3.7M217K
Dec 17, 2025Grant(A)50K—$097K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 17, 2025Grant(A)65K—$065K

Transaction Codes

A
Grant / award
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-326774) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML